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Abstract 
In recent years, the progress of stem cell research along with the need for stem cell-
based therapy, has brought researchers to focus on finding new stem cell populations, 
which hold advantages over the already known. For that reason, the ethical, 
histocompatibility and technological issues have led scientists to discover a new stem 
cell population, namely, very small embryonic like stem cells (VSELs). These cells 
were characterized as small-seized, quiescent with high nuclei/cytoplasmic ratio and 
open type euchromatin. The most significant property is that they express several 
pluripotent stem cells markers and demonstrate the ability to differentiate into three 
germ-layer lineages. A lot of studies have already been performed for murine VSELs, 
only a few for human VSELs and all the results demonstrate that these stem cells can 
regenerate a lot of tissues and organs and maybe they play an important role in aging. 
However, further clinical and research studies on these cells need to be performed in 
the following years. In this paper, we will emphasize on the properties of VSELs and 
we will examine the therapeutic potential and the advantages they may hold. 
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BM                       Bone marrow  
EPCs                    Endothelial progenitor cells 
ESCs                    Embryonic stem cells 
FACS                   Fluorescence-activated cell sorting 
G-CSF                  Granulocyte colony-stimulating factor  
GH                        Circulating growth hormone   
HSCs                     Ηematopoietic stem cells 
IGF-1                     Insulin/insulin like growth factor-1  
IGF2R                    Insulin-like growth factor 2 receptor 
INS                         Insulin 
iPSCs                      Induced pluripotent stem cells 
MAPCs                   Μultipotent adult progenitor cells 
MHC-I                    Major histocompatibility complex Class I  
MHC-II                   Major histocompatibility complex Class II 
MNC                       Mononuclear cell 
MIAMI                   Μarrow-isolated adult multilineage inducible  
MSCs                      Mesenchymal stem cells 
PGCs                       Primordial germ cells  
PPAR-γ                   Peroxisome proliferator-activated receptor gamma 
RasGrf1                   Ras protein-specific guanine nucleotide-releasing factor 1 
SCF                         Stem cell factor  
SDF-1a                    Stromal cell-derived factor 1a  
VSELs                     Very small embryonic like stem cells 
UCB                         Umbilical cord blood 










Embryonic stem cells (ES) are 
pluripotent stem cells, derived from 
blastocyst, which express cell surface 
markers that characterize primary 
embryonic stem cells and they present 
high telomerase activity (Thomson et 
al., 1998). Recently, owing to the 
progress of stem cell research, a new 
stem cell population with embryonic 
properties was discovered, namely, 
very small embryonic like stem cells 
(VSELs). Kucia et al. at Louisville’s 
University firstly isolated VSELs in 
2006 from murine bone marrow. These 
cells displayed stem cell properties and 
were characterized as small-seized cells 
with large nuclei and open-type 
euchromatin (Kucia et al., 2006). 
Previous studies, which identified a 
population of non-hematopoietic stem 
cells (non-HSCs) in BM described these 
cells as: multipotent adult progenitor 
cells (MAPCs) or marrow-isolated 
adult multilineage inducible (MIAMI) 
cells or they did not name the cell 
population. (Jiang et al., 2002; 
D'Ippolito et al., 2004). Eventually 
some years later many research groups 
have successfully confirmed the 
existence of VSELs (Virant-Klun et al., 
2008; Sovalat et al., 2011; Bhartiya et 
al., 2012a; Kassmer et al., 2013; 
Tsagias et al., 2015). 
An overview of the properties of 
VSELs, the potential applications and 
the results from clinical and research 
studies is presented here, in order to 
understand the great abilities that these 
stem cells can offer to medicine 
expanding the scientific field of 
regenerative medicine. For this 
purpose, we included original articles 
from scientific databases such as 
PubMed, Scopus and Google Scholar. 
Characterization of VSELs 
VSELs isolated from UCB are very 
small (3-5μm) with large nuclei and 
unorganized euchromatin, are enriched 
withCXCR4(+)AC133(+)CD34(+)lin(-
)CD45(-) CB mononuclear cells and 
express the surface embryonic antigen 
SSEA-4 and embryonic transcription 
factors Oct-4 and Nanog (Kucia et 
al.,2007). Studies performed on mice 
have shown that VSELs were found in 
several organs such as pancreas, 
muscles, brain, kidneys, BM and fetal 
liver (Zuba-Surma et al.,2008a; Zuba-
Surma et al., 2009). According to 
Bhartiya et al VSELs are also present in 
human reproductive tissues (Bhartiya et 
al., 2013). They have also been 
identified in peripheral blood after 
mobilization and they were successfully 
isolated from umbilical cord blood 
(Kucia et al., 2007; Ratajczak et al., 
2011a; Bhartiya et al., 2012b; Marlicz 
et al., 2012; Gounari et al., 2019;). 
Recently VSELs have been found in 
human cardiac tissue (El-Helw et al., 
2020). Normally VSELs remain 
quiescent, but under tissue injury or 
stress, such as muscle and liver injury, 
myocardial infarction, myocardial 
ischemia, intermittent hypoxia, stroke, 
skin burn injury and Crohn’s disease 
they become activated and they 
mobilize to the affected area (Kucia et 
al.,2008; Zuba-Surma et al., 2008b; 
Paczkowska et al., 2009; Abdel-Latif et 
al., 2010; Gharib et al., 2010; Drukała 
et al., 2012; Marlicz  et al., 2012). 
Moreover, there are studies, which 
indicate that the mobilization of VSELs 
can be caused by treatment with 
granulocyte colony-stimulating factor 
(G-CSF) (Kucia et al., 2008; Havens et 
al., 2013).  
Lahlil et al observed that many 
populations of VSELs may exist and 
they tried to characterize their 
capability of expansion and 
differentiation. For the first time VSELs 
were expanded in vitro without feeder 
cells, but the cells presented great 
expansion and maintained their 
capability to differentiate into 
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endothelial and hematopoietic cells 
only with specific medium 
supplemented with pyrimidoindole 
derivative (UM171). Moreover, their 
results showed that Lin-CD34 + CD45- 
VSELs, which express CD133+ or 
NANOG+ possess the same capability 
for differentiation and expansion, in 
contrast to Lin-CD34 + CD45- VSELs, 
which express CXCR4 marker and they 
are less able to expand and differentiate 
(Lahlil et al., 2018). 
Furthermore, it has been proven, that 
VSELs can differentiate in vitro, when 
stimulated properly, into cells of all the 
three embryonic layers, such as 
neurons, osteoblasts, adipocytes and 
chondrocytes (Havens et al., 2014). 
Also, many clinical studies proved that 
these cells maintain their regenerative 
properties in vivo (Taichman et al., 
2010; Zuba-Surma et al., 2011; 
Bhartiya, 2014a; Bhartiya et al., 2014b; 
Chen et al., 2015). 
Origin of VSELs 
It is thought that VSELs originate from 
primordial germ cells (PGCs), which 
are pluripotent stem cells formed by 
embryo’s epiblast. In support of this 
concept, like PGCs, VSELs can give 
rise to HSCs and EPCs (Ohtaka et al., 
1999; Kritzenberger and Wrobel, 2004; 
Ratajczak J et al., 2011a; Ratajczak J et 
al., 2011b). Also, PGCs, VSELs and 
HSCs express the erythropoietin 
receptor and sex hormone receptors 
(Suszynska et al., 2014; Mierzejewska 
et al., 2015). Additionally, VSELs 
express hemangioblast markers and can 
form endothelial cells both in vitro and 
in vivo (Shin et al.,2010; Guerin et al., 
2015). Moreover, both PGCs and 
VSELs cannot divide into cell cultures, 
they have the ability to differentiate into 
all three germ layers and they express 
pluripotent (Sox2, Nanog, Oct4) and 
PGC (Fragilis, Stella) markers (Shin et 
al.,2010). 
 
Differentiation potential of VSELs 
When stimulated in vitro, VSELs can 
differentiate into cells of the three 
embryonic layers such as neurons, 
osteoblasts, adipocytes and 
chondrocytes (Havens et al., 2014). It 
has also been demonstrated that VSELs 
can undergo differentiation into germ 
and hematopoietic cells in vitro (Shaikh 
et al., 2017). There are several studies 
which indicate, that apart from 
hematopoietic differentiation VSELs 
can differentiate into endothelial cells 
both in vitro and in vivo (Ohtaka et al., 
1999; Kritzenberger et al., 2004; Shin et 
al.,2010; Ratajczak  et al., 2011a; 
Ratajczak et al., 2011b; Guerin et al., 
2015). It has also been demonstrated 
that VSELs from murine bone marrow 
can differentiate into cardiomyocytes 
and epithelial cells of the lung 
(Wojakowski et al., 2010; Kassmer et 
al., 2013). Furthermore, VSELs were 
successfully differentiated into HSCs 
when cocultured with WJ-MSCs feeder 
cells (Gounari et al., 2019). In addition 
to this study a previous one 
demonstrated that when VSELs were 
cultured in specific medium containing 
pyrimidoindole derivative (UM171), 
they presented for the first-time great 
cell expansion without feeder cells and 
they maintained their capability to 
differentiate into hematopoietic and 
endothelial cells (Lahlil et al., 2018). 
Isolation of VSELs 
The small size of VSELs has led to 
efficient strategies in order to obtain 
these rare stem cells. The first method is 
cell isolation by ficoll-hypaque density 
centrifugation. Blood obtained from 
both UC and BM is overlaid on ficoll-
hypaque and centrifuged in order to 
form 4 layers (plasma, mononuclear 
cells, granulocytes, erythrocytes). The 
erythrocyte’s layer is centrifuged again 
to separate erythrocytes and the pellet 
obtained is enriched with VSELs. This 
step is followed by sorting with FACS 
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(Bhartiya et al.,2012b). This method is 
cheap and can be easily carried out, but 
many VSELs can be lost.  
Due to the increased loss of VSELs 
when applying the ficoll method, 
another method was discovered, which 
includes cell isolation with erythrocyte 
lysis. The UCB is mixed with buffered 
solution that causes lysis of 
erythrocytes such as hypotonic 
ammonium chloride and then 
centrifuged until the erythrocytes are 
completely removed. The last step is to 
discard the supernatant, suspend the 
bottom pellet into RPMI medium and 
sort the cells by FACS (Zuba-Surma et 
al.,2010). This is a short (three steps 
only) quick and economical protocol 
that allows recovery of approximately 
60% of the initial number of UCB-
VSELs present in freshly harvested 
UCB units. 
Finally, a novel method for isolation of 
VSELs was proposed by Gounari et al. 
in 2019. Firstly, blood from UC is 
overlaid on ficoll and then the material 
is centrifuged with gradually increased 
spins. Afterwards the cells are cultured 
with Alpha-MEM medium, which is 
supplemented with Stromal cell-
derived factor 1a (SDF-1a). After 
incubation VSELs migrate 
chemotactically towards the SDF-1a 
factor (Gounari et al., 2019). This 
strategy is rapid, low cost, it doesn’t 
demand special equipment, it is simpler 
as FACS sorting and most importantly 
other cell populations could be 
simultaneously isolated from UC. 
Therapeutic potential (application) 
of VSELs 
Although VSELs are rare and hard to 
isolate owing to their small size, they 
possess embryonic stem cells properties 
and for that reason they hold great 
potential for medical applications.  
First, studies performed in mice have 
shown that BM-derived VSELs can 
improve the function of left ventricular 
after myocardial infarction, supporting 
that they may promote cardiac repair 
(Dawn et al.,2008; Zuba-Surma et 
al.,2011). Furthermore, the fact that 
VSELs transplantation could support 
cardiomyocytes survival in the 
ischemic area indicates that VSELs may 
prevent apoptosis of ischemic 
myocardium (Dawn et al., 2008). A 
recent study proved for the first time the 
existence of VSELs in human adult 
heart and confirmed that these cells 
were decreased during aging, indicating 
the need for further studying of the 
regenerative and therapeutic potential 
of VSELs to cardiac tissue (El-Helw et 
al.,2020)  
There is also evidence that VSELs 
could restore fertility in cancer 
survivors and this was supported by the 
fact that when busulfan, a 
chemotherapy drug was inserted in 
mice’s testes, VSELs survived 
chemotherapy and restored 
spermatogenesis in germ cells 
(Bhartiya, 2014a).  
Moreover, the same year Bhartiya et al 
demonstrated the capability of VSELs 
to regenerate mouse pancreas after 
partial pancreatomy and as a result they 
claimed that this stem cell population 
could be an alternative to ES/iPS cells 
to regenerate a diabetic pancreas 
(Bhartiya et al., 2014b). Also, 
Mohammad et al in 2020 reported that 
VSELs were increased in mouse 
diabetic pancreas after treatment with 
streptozotocin and they hold the 
potential to regenerate diabetic 
pancreas, as after partial pancreatomy 
they could cause neogenesis of islets 
and canals in pancreas (Mohammad et 
al., 2020). 
Another very interesting study, which 
was carried out by Chen et al was 
focused on the similarities and 
differences between the gene 
expression of VSELs obtained from 
mice BM and ES. They demonstrated 
that VSELs express stem cell factor 
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(SCF) receptor and when hepatic 
growth factor is present, they can 
differentiate in vitro into hepatic cells. 
Moreover, they showed that VSELs 
maintain their regenerative properties in 
vivo and this was proven by the fact that 
when cells were transplanted into 
injured liver, they played a significant 
role in the repair of liver’s injuries 
(Chen et al., 2015). 
Another study indicates that VSELs 
hold mesenchymal stem cell properties 
and they can differentiate in vivo into 2 
mesenchymal lineages, osteoblasts-
Runx-2 and adipocytes-PPARγ, so it is 
proposed that an isolated population of 
only 500 mononucleated cells 
(Lin−Sca-1+CD45−) could regenerate 
in vivo a bone (Taichman et al.,2010). 
A recent study also proves that VSELs 
can lead to bone healing and they can 
play a significant role in bone formation 
induced by BM-MNC (Leppik et al., 
2020). 
Additionally, a research group isolated 
BM-VSELs from patients with critical 
limb ischemia and tested their 
angiogenic and therapeutic potential in 
mouse models with critical limb 
ischemia. Their results showed that 
VSELs can differentiate in vivo into 
endothelial cells by presenting 
angiogenic properties and thus they 
possess a mesenchymal cell phenotype 
in vitro, which makes them an ideal 
source of therapeutic cells (Guerin et 
al., 2015). 
Also, Guerin et al examined the 
mobilization of VSELs from the BM to 
peripheral blood in patients with 
hypoxic lung disease or pulmonary 
hypertension and they demonstrated 
that the number of VSELs was higher in 
the peripheral blood of both group of 
patients and therefore VSELs can play 




VSELs and Aging  
In 2011 Borras et al demonstrated that 
RasGrf1 deficiency promotes mice 
longevity and the lifespan of 
RasGrf1−/− knockout mice was 
increased by 20% approximately. They 
indicated that RasGrf1−/− mice display 
lower levels of circulating growth 
hormone (GH) and insulin/insulin like 
growth factor-1 (IGF-1) in peripheral 
blood (Borras et al., 2011). There is also 
evidence that growth factor (GH), 
insulin (INS) and insulin like growth 
factor signal can promote aging and 
decrease the number of VSELs and as 
an result it is recommended to test if 
VSELs from a newborn’s UC that will 
be harvested, cryopreserved and then 
transplanted when the donor gets older, 
could offer rejuvenation to his/her 
organs or functions (Ratajczak et 
al.,2017). 
Specifically it is documented that 
murine VSELs modulate through 
epigenetic changes imprinted genes 
such as  Igf2-H19, RasGRF1, and 
IGF2R, which take part in 
insulin/insulin-like growth factors 
signaling (IIS) and play a significant 
role in maintaining the number of 
VSELs in adult tissues and helps 
VSELs resist against aging  (Shin et al., 
2009; Kucia et al., 2013) 
In addition a recent study performed on 
mice showed that both VSELs and 
HSCs in BM are affected by age and 
specifically the research group 
indicated that the proliferation ability in 
older mice was not affected by age, but 
the differentiation dynamic was 
decreased and so was their ability to 
restore homeostasis after treatment with 
a stressful factor (Ganguly et al., 2020). 
As a result, more research and clinical 
studies need to be performed in order to 
find out how VSELs can be used for 
lifespan expansion or organ’s 
rejuvenation of older individuals.  
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Advantages of VSELs 
After the discovery of VSELs many 
studies were performed in order to 
isolate this stem cell population and use 
it in several experiments to identify the 
therapeutic potential these cells may 
hold. So, it is really important to verify 
whether VSELs are better and more 
approachable than ESCs and iPSCs. 
Considering the sources, that these cells 
are obtained, there aren’t serious ethical 
problems for clinical applications, in 
contrast to ESCs and iPSCs and the 
most important advantage is that 
VSELs don’t form teratomas in animal 
experiments (Dimomeletis et al., 2010). 
Furthermore, VSELs are an ideal stem 
cell population with embryonic stem 
cell properties, which can be used in 
regenerative medicine, because these 
stem cells do not express MHC-I and 
MHC-II antigens (Ratajczak et al., 
2008). 
Conclusion  
Murine VSELs from different sources 
have been well characterized both at the 
morphological and molecular level and 
it has been reported that they express 
many markers, which support their 
pluripotent character. Moreover, 
several studies have demonstrated that 
these cells present embryonic stem cell 
properties, and the most significant fact 
is that they have the ability to 
differentiate into cells from all the three 
germ layers. These findings open the 
way to therapeutic applications in 
regenerative medicine. Significant 
progress has been made recently, 
including characterization, isolation, 
expansion and in vitro experiments of 
human VSELs. Furthermore, the fact 
that VSELs hold embryonic properties 
but do not form teratomas and they do 
not express major histocompatibility 
complex (Class I and II) makes them an 
ideal stem cell population in 
regenerative medicine. It is also very 
interesting that VSELs in addition to 
tissue and organ regeneration could 
contribute also to rejuvenation and 
lifespan expansion, but this surely 
needs further studies. In conclusion, 
VSELs constitute a very promising 
stem cell population of regenerative 
medicine, which holds several 
therapeutic potential and for that reason 
more research and clinical studies need 
to be performed in the following years. 
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